Nasostop
Nasostop
Composition and form of release:
Active ingredient: Xylometazoline hydrochloride 0.5 mg \ 1 ml
Nasal drops as a clear, colorless solution, plastic bottle.
Pharmachologic effect:
A vasoconstrictor for topical use in ENT practice. When applied to mucous membranes, it causes vasoconstriction, as a result of which local hyperemia and edema decrease. With rhinitis, it makes nasal breathing easier.
Do not use the drug in children without specialist advice for more than 5 days in order to avoid atrophy of the nasal mucosa.
Indications:
Symptomatic treatment of nasal congestion in chronic, year-round and acute rhinitis (including allergic and associated with flowering), sinusitis.
Contraindications:
-Individual intolerance to the components of the drug.
-Patients after removal of the pituitary gland or other surgical interventions on the brain in history.
– Children under 6 years old.
– Angle-closure glaucoma.
– Atrophic rhinitis.
– Arterial hypertension, tachycardia, severe atherosclerosis.
– Hyperthyroidism.
– Diabetes.
– Pheochromacytoma.
– Inflammation of the skin and mucous membranes of the vestibule of the nose.
Side effects:
With frequent and / or prolonged use: irritation of the mucous membrane, burning, tingling, sneezing, dry nasal mucosa, hypersecretion.
Rarely: swelling of the nasal mucosa (more often with prolonged use), palpitations, cardiac arrhythmias, increased blood pressure, headache, vomiting, sleep disorders, visual impairment.
With long-term use in high doses: depressive state.
Dosing regimen:
Intranasally. In children from 6 to 12 years old, 1-2 drops in each nasal passage 1-2 times a day.
Storage method:
Store at a temperature not exceeding 30 degrees
Packaging:
Bottle 15 ml